Tina Nova, Scott Garrett, John Wareham, William Rastetter, John Stuelpnagel | GenomeWeb

Cyntellect announced this week the appointment of Tina Nova to the company’s board of directors. Nova is the president, CEO and co-founder of Genoptix. She also co-founded Nanogen, where she served as chief operating officer and president from 1994 to 2000. In addition, Nova served as chief operating officer of Selective Genetics from 1992-1994, and held various director-level positions with Ligand Pharmaceuticals from 1988 to 1992.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.